Inhibition of Allogeneic T Cell Proliferation by Indoleamine 2,3-Dioxygenase–expressing Dendritic Cells

Journal of Experimental Medicine - Tập 196 Số 4 - Trang 447-457 - 2002
Peter Terness1, Thomas M. Bauer1, Lars Röse1, C Dufter1, A Watzlik1, Helmut Simon1, Gerhard Opelz1
1Institute of Immunology, Department of Transplantation Immunology, University of Heidelberg, 69120 Heidelberg, Germany

Tóm tắt

Indoleamine 2,3-dioxygenase (IDO), an enzyme involved in the catabolism of tryptophan, is expressed in certain cells and tissues, particularly in antigen-presenting cells of lymphoid organs and in the placenta. It was shown that IDO prevents rejection of the fetus during pregnancy, probably by inhibiting alloreactive T cells, and it was suggested that IDO-expression in antigen-presenting cells may control autoreactive immune responses. Degradation of tryptophan, an essential amino acid required for cell proliferation, was reported to be the mechanism of IDO-induced T cell suppression. Because we wanted to study the action of IDO-expressing dendritic cells (DCs) on allogeneic T cells, the human IDO gene was inserted into an adenoviral vector and expressed in DCs. Transgenic DCs decreased the concentration of tryptophan, increased the concentration of kynurenine, the main tryptophan metabolite, and suppressed allogeneic T cell proliferation in vitro. Kynurenine, 3-hydroxykynurenine, and 3-hydroxyanthranilic acid, but no other IDO-induced tryptophan metabolites, suppressed the T cell response, the suppressive effects being additive. T cells, once stopped in their proliferation, could not be restimulated. Inhibition of proliferation was likely due to T cell death because suppressive tryptophan catabolites exerted a cytotoxic action on CD3+ cells. This action preferentially affected activated T cells and increased gradually with exposure time. In addition to T cells, B and natural killer (NK) cells were also killed, whereas DCs were not affected. Our findings shed light on suppressive mechanisms mediated by DCs and provide an explanation for important biological processes in which IDO activity apparently is increased, such as protection of the fetus from rejection during pregnancy and possibly T cell death in HIV-infected patients.

Từ khóa


Tài liệu tham khảo

1980, Arch. Biochem. Biophys., 203, 343, 10.1016/0003-9861(80)90185-X

1991, FASEB J., 5, 2516, 10.1096/fasebj.5.11.1907934

1999, Immunol. Today., 20, 469, 10.1016/S0167-5699(99)01520-0

1979, Proc. Natl. Acad. Sci. USA., 76, 4084, 10.1073/pnas.76.8.4084

1978, Proc. Natl. Acad. Sci. USA., 75, 3998, 10.1073/pnas.75.8.3998

1987, J. Immunol., 139, 2414, 10.4049/jimmunol.139.7.2414

1988, Biochem. Biophys. Res. Commun., 152, 237, 10.1016/S0006-291X(88)80705-8

1999, J. Immunol., 162, 957, 10.4049/jimmunol.162.2.957

1984, Proc. Natl. Acad. Sci. USA., 81, 908, 10.1073/pnas.81.3.908

1996, Infect. Immun., 64, 4188, 10.1128/iai.64.10.4188-4196.1996

1986, Infect. Immunol., 53, 347, 10.1128/iai.53.2.347-351.1986

1988, Cancer Res., 48, 346

1989, J. Clin. Invest., 84, 863, 10.1172/JCI114247

1999, J. Exp. Med., 189, 1363, 10.1084/jem.189.9.1363

1998, Science., 281, 1191, 10.1126/science.281.5380.1191

1991, Acta Med. Okayama., 45, 135

1998, Proc. Natl. Acad. Sci. USA., 95, 2509, 10.1073/pnas.95.5.2509

1997, Adv. Exp. Med. Biol., 417, 7, 10.1007/978-1-4757-9966-8_2

1988, J. Biol. Chem., 263, 2041, 10.1016/S0021-9258(19)77982-4

2000, Gene Ther., 7, 70, 10.1038/sj.gt.3301050

1987, Life Sci., 41, 273, 10.1016/0024-3205(87)90149-4

2000, Mod. Asp. Immunobiol., 1, 105

1967, J. Biol. Chem., 242, 5260, 10.1016/S0021-9258(18)99420-2

1994, Cell Tissue Res., 278, 461, 10.1007/BF00331364

2000, J. Immunol., 164, 3596, 10.4049/jimmunol.164.7.3596

1998, Nature., 392, 245, 10.1038/32588

2000, J. Immunol., 165, 1357, 10.4049/jimmunol.165.3.1357

1996, Obstet. Gynecol., 88, 47, 10.1016/0029-7844(96)00084-1

2001, J. Immunol., 167, 708, 10.4049/jimmunol.167.2.708

1998, FASEB J., 12, 881

1991, Adv. Exp. Med. Biol., 294, 425, 10.1007/978-1-4684-5952-4_39

1999, Am. J. Obstet. Gynecol., 181, 1452, 10.1016/S0002-9378(99)70391-1

2001, J. Neurochem., 77, 1310, 10.1046/j.1471-4159.2001.00335.x

1999, Eur. J. Neurosci., 11, 3857, 10.1046/j.1460-9568.1999.00806.x

1996, J. Immunol., 156, 523, 10.4049/jimmunol.156.2.523

1999, J. Immunol., 163, 2517, 10.4049/jimmunol.163.5.2517

2001, J. Immunol., 166, 277, 10.4049/jimmunol.166.1.277

2000, J. Neurochem., 75, 81, 10.1046/j.1471-4159.2000.0750081.x

1998, J. Neurochem., 70, 299, 10.1046/j.1471-4159.1998.70010299.x

1991, Ann. Neurol., 29, 202, 10.1002/ana.410290215

2000, J. Virol., 74, 4110, 10.1128/JVI.74.9.4110-4115.2000

1998, Clin. Chem., 44, 858, 10.1093/clinchem/44.4.858

1996, Transplantation., 62, 659, 10.1097/00007890-199609150-00021

1995, Transplantation., 60, 1366

Thông tin
Thông tin xuất bản

Journal of Experimental Medicine

Tập 196 Số 4

447-457

Thông tin tác giả